Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

STEMCELL Technologies IntestiCult™ Organoid Growth Medium (Human)
SDP

Supplier:  STEMCELL Technologies 06010

Encompass

Model key characteristics of the adult intestinal epithelium using intestinal organoids established and maintained with this complete medium and optimized protocol. Derive organoids from human intestinal crypts in one week; enable organoid growth across donor samples, including those that are difficult to grow, by an enriched stem cell population. Organoids grown in this medium incorporate a functional lumen enclosed by a polarized intestinal epithelial layer, and can be further differentiated in 3D or in 2D as submerged monolayers or air-liquid interface (ALI) cultures using IntestiCult™ Organoid Differentiation Medium (Human; Catalog #100-0214). Applications of intestinal organoid cultures include developmental studies, disease modelling, investigation of adult stem cell properties, regenerative medicine, and compound screening.Should you intend to use this product for commercial purposes, please contact HUB Organoids B.V. at www.huborganoids.nl

Catalog No. NC1360724


May include imposed supplier surcharges.
Only null left
Add to Cart
This item is not returnable. View return policy

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.